東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Development of a new optical imaging...

Thompson, Alan Bruce, Jr.

Linked to FindBook

Google Book

Amazon

博客來

Development of a new optical imaging modality for detection of fluorescence-enhanced disease.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Development of a new optical imaging modality for detection of fluorescence-enhanced disease./
Author:	Thompson, Alan Bruce, Jr.
Description:	180 p.
Notes:	Source: Dissertation Abstracts International, Volume: 64-04, Section: B, page: 1827.
Contained By:	Dissertation Abstracts International64-04B.
Subject:	Engineering, Chemical. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3088188

Development of a new optical imaging modality for detection of fluorescence-enhanced disease.
Thompson, Alan Bruce, Jr.

Development of a new optical imaging modality for detection of fluorescence-enhanced disease. - 180 p.

Source: Dissertation Abstracts International, Volume: 64-04, Section: B, page: 1827.

Thesis (Ph.D.)--Texas A&M University, 2003.

A new optical imaging modality has been developed for the detection of early breast disease enhanced with a fluorescent contrast agent that excites and reemits at near-infrared (NIR) wavelengths. This new modality is based on exciting the fluorescent agent using an expanded, intensity-modulated NIR light source and detecting diffuse, intensity-modulated NIR fluorescent light, or fluorescence frequency-domain photon migration (FDPM), using a gain-modulated intensified charge-coupled device (ICCD) camera system. In order to localize tissue-laden, fluorescence-enhanced targets from measurements acquired external to tissues, an inverse problem must be solved. Interior maps of tissue properties, which govern light transport, are iteratively updated by a tomographic reconstruction algorithm until experimental fluorescence data acquired external to tissues approximate data predicted by an appropriate mathematical model of light transport within tissues.Subjects--Topical Terms:

1018531
Engineering, Chemical.

Development of a new optical imaging modality for detection of fluorescence-enhanced disease.
LDR:03492nmm 2200289 4500 001 1856047
005 20040616162818.5
008 130614s2003 eng d
035 $a (UnM)AAI3088188
035 $a AAI3088188
040 $a UnM $c UnM
100 1 $a Thompson, Alan Bruce, Jr. $3 1943841
245 1 0 $a Development of a new optical imaging modality for detection of fluorescence-enhanced disease.
300 $a 180 p.
500 $a Source: Dissertation Abstracts International, Volume: 64-04, Section: B, page: 1827.
500 $a Chair: Eva M. Sevick-Muraca.
502 $a Thesis (Ph.D.)--Texas A&M University, 2003.
520 $a A new optical imaging modality has been developed for the detection of early breast disease enhanced with a fluorescent contrast agent that excites and reemits at near-infrared (NIR) wavelengths. This new modality is based on exciting the fluorescent agent using an expanded, intensity-modulated NIR light source and detecting diffuse, intensity-modulated NIR fluorescent light, or fluorescence frequency-domain photon migration (FDPM), using a gain-modulated intensified charge-coupled device (ICCD) camera system. In order to localize tissue-laden, fluorescence-enhanced targets from measurements acquired external to tissues, an inverse problem must be solved. Interior maps of tissue properties, which govern light transport, are iteratively updated by a tomographic reconstruction algorithm until experimental fluorescence data acquired external to tissues approximate data predicted by an appropriate mathematical model of light transport within tissues.
520 $a Area illumination and area detection, which have been designed to occur on the same tissue surface, are ideally suited for the clinic given their ease of implementation. Furthermore, area illumination can be used to efficiently excite fluorophores within a large tissue volume, and area detection can be used to provide large amounts of data, which benefit the underdetermined inverse problem. Measurement precision (reproducibility), measurement accuracy (agreement with a mathematical model), the target depth, and the target-to-background (T/B) ratio of fluorescent agent crucially impact whether target localization via tomographic reconstruction is feasible. Hence, important contributions in this work include: (1) determining the data acquisition parameters that maximize measurement precision; (2) developing a technique to spatially resolve the modulation amplitude and phase of the incident, area excitation source, which are needed to accurately compute the fluorescence FDPM data predicted by the mathematical model; (3) demonstrating that the coupled photon diffusion equations can be used to reasonably model experimental fluorescence FDPM data acquired from several 512-mL, homogeneous tissue phantoms, or tissue-mimicking media, each containing a 1-mL target immersed either 1 or 2 cm deep and enhanced with either a 1-μM solution of indocyanine green (ICG) or a 1.4-μM solution of 3,3<super>′</super>-diethylthiatricarbocyanine iodide (DTTCI); and (4) demonstrating how the target depth and the TB ratio of fluorescent agent impact the detectability of the target.
590 $a School code: 0803.
650 4 $a Engineering, Chemical. $3 1018531
650 4 $a Health Sciences, Oncology. $3 1018566
650 4 $a Engineering, Electronics and Electrical. $3 626636
690 $a 0542
690 $a 0992
690 $a 0544
710 2 0 $a Texas A&M University. $3 718977
773 0 $t Dissertation Abstracts International $g 64-04B.
790 1 0 $a Sevick-Muraca, Eva M., $e advisor
790 $a 0803
791 $a Ph.D.
792 $a 2003
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3088188